|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
25 Propionil L-Carnitina structura chimica
26 27 28 29
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Acetil L-Carnitina poate dona grupa de acetil in prezenta de Coenzima
A pentru productia de
| Dr.
MD. Roy L. Waldford, Lisa Waldford - The Anti-Aging Plan: Strategies and Recipes for Extending Your Healthy Years |
 Crono
Forte - Formula Anti-Aging 3 Capsule contine: |
 |
|
Mod
de administrare:Terapia Anti-Aging:
Anti-Aging-Systeme - Formula AntiAging
Anti-Aging-Systeme - Terapia Anti-Aging
Bibliografie - Referinte Acetil L-Carnitina
Informatii din bibliografia electronica la tema: Nutritie si sanatate
1. White HL, Scates PW. Acetyl-L-carnitine as a precursor of acetylcholine. Division
of Pharmacology, Wellcome Research Laboratories, Research Triangle Park, North
Carolina 27709. Neurochem Res. 1990 Jun;15(6):597-601.
- Traina G, Valleggi S, Bernardi R, Rizzo M, Calvani M, Nicolai R, Mosconi L,
Durante M, Brunelli M. Identification of differentially expressed genes induced
in the rat brain by acetyl-L-carnitine as evidenced by suppression subtractive
hybridisation. Dipartimento di Fisiologia e Biochimica G. Moruzzi, Universita
di Pisa, Via S. Zeno, 31, 56127 Pisa, Italy. gtraina@dfb.unipi.it Brain Res Mol
Brain Res. 2004 Dec 6;132(1):57-63.
2. Aureli T, Miccheli A, Ricciolini R, Di Cocco ME, Ramacci MT, Angelucci
L, Ghirardi O, Conti F. Aging brain: effect of acetyl-L-carnitine treatment
on
rat brain energy and phospholipid metabolism. A study by 31P and 1H NMR spectroscopy.
Department of Chemistry, University of Rome La Sapienza, Italy. Brain Res.
1990 Aug 27;526(1):108-12.
3. Ando S, Tadenuma T, Tanaka Y, Fukui F, Kobayashi S, Ohashi Y, Kawabata T.
Enhancement of learning capacity and cholinergic synaptic function by carnitine
in aging rats. J Neurosci Res 2001 Oct 15;66(2):266-71
4. Tanaka Y, Sasaki R, Fukui F, Waki H, Kawabata T, Okazaki M, Hasegawa K,
Ando S. Acetyl-L-carnitine supplementation restores decreased tissue carnitine
levels
and impaired lipid metabolism in aged rats. Neuronal Function Research Group,
Division of Neuroscience and Brain Function, Tokyo Metropolitan Institute of
Gerontology, 35-2 Sakaecho, Itabashi-ku, Tokyo 173-0015, Japan. J Lipid Res.
2004 Apr;45(4):729-35. Epub 2004 Jan 1.
5. Seidman MD, Khan MJ, Bai U, Shirwany N, Quirk WS. Biologic activity of mitochondrial
metabolites on aging and age-related hearing loss. Department of Otolaryngology
Head & Neck
Surgery, Henry Ford Health System, Detroit, Michigan 48323, USA. Am J Otol. 2000
Mar;21(2):161-7.
6. Inano A, Sai Y, Nikaido H, Hasimoto N, Asano M, Tsuji A, Tamai I. Acetyl-L-carnitine
permeability across the blood-brain barrier and involvement of carnitine transporter
OCTN2. Faculty of Pharmaceutical Sciences, Kanazawa University, 13-1 Takara-machi,
Kanazawa 920-0934, Japan. Biopharm Drug Dispos. 2003 Nov;24(8):357-65.
7. Napoleone P, Ferrante F, Ghirardi O, Ramacci MT, Amenta F. Age-dependent nerve
cell loss in the brain of Sprague-Dawley rats: effect of long term acetyl-L-carnitine
treatment. Dipartimento di Scienze Neurologiche, Universita 'La Sapienza', Rome,
Italy. Arch Gerontol Geriatr. 1990 Mar-Apr;10(2):173-85
8. McKay Hart A, Wiberg M, Terenghi G. Pharmacological enhancement of peripheral
nerve regeneration in the rat by systemic acetyl-L-carnitine treatment. Blond-McIndoe
Centre, Royal Free and University College Medical School, University Department
of Surgery, Royal Free Campus, Rowland Hill Street, London NW3 2PF, UK. Neurosci
Lett. 2002 Dec 16;334(3):181-5.
9. Florio T, Meucci O, Grimaldi M, Ventra C, Cocozza E, Avallone A, Postiglione
A, Marino A, Schettini G. Effect of acetyl-L-carnitine treatment on brain adenylate
cyclase activity in young and aged rats. Dipartimento di Scienza delle Communicazioni
Umane, II Facolta di Medicina e Chirurgia, Universita degli Studi di Napoli,
Italy. Eur Neuropsychopharmacol. 1993 Jun;3(2):95-101.
10. Taglialatela G, Navarra D, Olivi
A, Ramacci MT, Werrbach-Perez K, Perez-Polo JR, Angelucci L. Neurite outgrowth
in
PC12 cells stimulated by acetyl-L-carnitine
arginine amide. Institute for Research on Senescence Sigma-Tau, Pomezia, Italy.
Neurochem Res. 1995 Jan;20(1):1-9.
11. McDaniel MA, Maier SF, Einstein GO. "Brain-specific" nutrients:
a memory cure Department of Psychology, University of New Mexico, Albuquerque,
New Mexico 87131, USA. Nutrition. 2003 Nov-Dec;19(11-12):957-75.
12. Bruno G, Scaccianoce S, Bonamini M,
Patacchioli FR, Cesarino F, Grassini
P, Sorrentino E, Angelucci L, Lenzi GL.
Acetyl-L-carnitine in Alzheimer disease: a short-term study on CSF neurotransmitters
and neuropeptides. Dipartimento di Scienze Neurologiche, Universita di Roma La
Sapienza, Italy. Alzheimer Dis Assoc Disord. 1995 Fall;9(3):128-31.
- Brooks JO 3rd, Yesavage JA, Carta A, Bravi D. Acetyl L-carnitine slows decline
in younger patients with Alzheimer's disease: a reanalysis of a double-blind,
placebo-controlled study using the trilinear approach. Stanford University School
of Medicine, California, USA. johnbrks@stanford.edu. Int Psychogeriatr. 1998
Jun;10(2):193-203.
- Rai G, Wright G, Scott L, Beston B, Rest J, Exton-Smith AN. Double-blind, placebo
controlled study of acetyl-l-carnitine in patients with Alzheimer's dementia.
Department of Geriatric Medicine, Whittington Hospital, London, England. Curr
Med Res Opin. 1990;11(10):638-47.
- Pettegrew JW, Klunk WE, Panchalingam K, et al. Clinical and neurochemical effects
of acetyl-L-carnitine in Alzheimer’s
disease. Neurobiol Aging. 1995 Jan-Feb;16(1):1-4.
- Spagnoli A, Lucca U, Menasce G, et al. Long-term acetyl-L-carnitine treatment
in Alzheimer’s
disease. Neurology. 1991 Nov;41(11):1726-32.
- Carta A, Calvani M, Bravi D, Bhuachalla SN. Acetyl-L-carnitine and Alzheimer's
disease: pharmacological considerations beyond the cholinergic sphere. Sigma-Tau
Pharmaceuticals, Department of Scientific Affairs, Gaithersburg, Maryland 20878.
Ann N Y Acad Sci. 1993 Sep 24;695:324-6.
13. Bianchetti A, Rozzini R, Trabucchi
M. Effects of acetyl-L-carnitine in Alzheimer's disease patients unresponsive
to acetylcholinesterase inhibitors. Geriatric Research
Group, Brescia, Italy. Curr Med Res Opin. 2003;19(4):350-3.
14. Passeri M, Cucinotta D, Bonati PA,
Iannuccelli M, Parnetti L, Senin U. Acetyl-L-carnitine in the treatment of mildly
demented elderly patients. Department of Internal
Medicine, University of Parma, Italy. Int J Clin Pharmacol Res. 1990;10(1-2):75-9.
- Cucinotta D, Passeri M, Ventura S, et al. Multicenter clinical placebo-controlled
study with acetyl-L-carnitine (LAC) in the treatment of mildly demented elderly
patients. Drug Development Res 1988;14:213-6.
- Bonavita E. Study of the efficacy and tolerability of L-acetylcarnitine therapy
in the senile brain. Int J Clin Pharmacol Ther Toxicol. 1986 Sep;24(9):511-6.
- Tempesta E, Casella L, Pirrongelli C, Janiri L, Calvani M, Ancona L. L-acetylcarnitine
in depressed elderly subjects. A cross-over study vs placebo. Department of Psychiatry
and Psychology, Catholic University of the Sacred Heart, Rome, Italy. Drugs Exp
Clin Res. 1987;13(7):417-23.
- Garzya G, Corallo D, Fiore A, Lecciso G, Petrelli G, Zotti C. Evaluation of
the effects of L-acetylcarnitine on senile patients suffering from depression.
Multizonal Garrison Hospital V. Fazzi, Geriatric Division, Lecce, Italy. Drugs
Exp Clin Res. 1990;16(2):101-6.
15. Brooks JO 3rd, Yesavage JA, Carta
A, Bravi D. Acetyl L-carnitine slows decline in younger patients with Alzheimer's
disease: a reanalysis of a double-blind,
placebo-controlled study using the trilinear approach. Stanford University School
of Medicine, California, USA. johnbrks@stanford.edu Int Psychogeriatr. 1998 Jun;10(2):193-203.
16. Salvioli G, Neri M. L-acetylcarnitine
treatment of mental decline in the elderly. Institute of Gerontology and Geriatrics,
Estense Hospital, University
of Modena, Italy. Drugs Exp Clin Res. 1994;20(4):169-76.
17. Tolu P, Masi F, Leggio B, Scheggi S, Tagliamonte A, De Montis MG, Gambarana
C. Effects of long-term acetyl-L-carnitine administration in rats: I. increased
dopamine output in mesocorticolimbic areas and protection toward acute stress
exposure. Department of Neuroscience, Pharmacology Unit, University of Siena,
Siena, Italy. Neuropsychopharmacology. 2002 Sep;27(3):410-20.
- Sershen H, Harsing LG Jr, Banay-Schwartz M, Hashim A, Ramacci MT, Lajtha A.
Effect of acetyl-L-carnitine on the dopaminergic system in aging brain. Center
for Neurochemistry, Nathan S. Kline Institute for Psychiatric Research, Orangeburg,
New York 10962. J Neurosci Res. 1991 Nov;30(3):555-9.
- Harsing LG Jr, Sershen H, Toth E, et al. Acetyl-L-carnitine releases dopamine
in rat corpus striatum: an in vivo microdialysis study. Eur J Pharmacol. 1992
Jul 21;218(1):117-21.
18. Beal MF. Bioenergetic approaches for neuroprotection in Parkinson's disease.
Department of Neurology and Neuroscience, Weill Medical College of Cornell University,
New York Presbyterian Hospital, New York, NY, USA. Ann Neurol. 2003;53 Suppl
3:S39-47; discussion S47-8.
19. Tomassini V, Pozzilli C, Onesti E, Pasqualetti P, Marinelli F, Pisani A,
Fieschi C. Comparison of the effects of acetyl L-carnitine and amantadine for
the treatment of fatigue in multiple sclerosis: results of a pilot, randomised,
double-blind, crossover trial. Department of Neurological Sciences, University
of Rome "La
Sapienza", viale dell' Universita 30, Rome 00185, Italy.
J Neurol Sci. 2004 Mar 15;218(1-2):103-8.
20. Hagen TM, Moreau R, Suh JH, Visioli F.Mitochondrial decay in the aging rat
heart: evidence for improvement by dietary supplementation with acetyl-L-carnitine
and/or lipoic acid. Department of Biochemistry and Biophysics, Linus Pauling
Institute, Oregon State University, Corvallis, Oregon 97331, USA.Ann N Y Acad
Sci. 2002 Apr;959:491-507.
- Hagen TM, Wehr CM, Ames BN. Mitochondrial decay in aging. Reversal through
supplementation of acetyl-L-carnitine and N-tert-butyl-alpha-phenyl-nitrone.Department
of Molecular and Cell Biology, University of California at Berkeley 94720, USA.
tory.hagen@orst.edu Ann N Y Acad Sci. 1998 Nov 20;854:214-23.
- Ames BN, Liu J. Delaying the mitochondrial
decay of aging with acetylcarnitine. Nutritional Genomics Center, Children's
Hospital Oakland Research Institute, 5700 Martin Luther King Jr. Way, Oakland,
CA 94609. bames@chori.org. Ann N Y Acad Sci. 2004 Nov;1033:108-16.
21. Liu J, Head E, Gharib AM, Yuan W, Ingersoll RT, Hagen TM, Cotman CW, Ames
BN. Memory loss in old rats is associated with brain mitochondrial decay and
RNA/DNA oxidation: partial reversal by feeding acetyl-L-carnitine and/or R-alpha
-lipoic acid. Division of Biochemistry and Molecular Biology, University of California,
Berkeley, CA 94720, USA.Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):2356-61.
Liu J, Killilea DW, Ames BN. Age-associated mitochondrial oxidative decay: improvement
of carnitine acetyltransferase substrate-binding affinity and activity in brain
by feeding old rats acetyl-L- carnitine and/or R-alpha -lipoic acid. Division
of Biochemistry and Molecular Biology, University of California, Berkeley, CA
94720, USA. Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):1876-81
22. Paradies G, Ruggiero FM, Petrosillo G, Gadaleta MN, Quagliariello E. Carnitine-acylcarnitine
translocase activity in cardiac mitochondria from aged rats: the effect of acetyl-L-carnitine.
Department of Biochemistry and Molecular Biology, University of Bari, Italy.
Mech Ageing Dev. 1995 Oct 13;84(2):103-12.
23. Hagen TM, Liu J, Lykkesfeldt J, Wehr CM, Ingersoll RT, Vinarsky V, Bartholomew
JC, Ames BN. Feeding acetyl-L-carnitine and lipoic acid to old rats significantly
improves metabolic function while decreasing oxidative stress. Department of
Biochemistry and Biophysics, Linus Pauling Institute, Oregon State University,
Corvallis, OR 97331, USA. Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):1870-5.
- Hagen TM, Ingersoll RT, Lykkesfeldt J,
et al. (R)-alpha-lipoic acid-supplemented old rats have improved mitochondrial
function, decreased oxidative damage, and increased metabolic rate. FASEB J.
1999; 13:411-418.
24. Ebeling P, Tuominen JA, Arenas J, Garcia Benayas C, Koivisto VA. The association
of acetyl-L-carnitine with glucose and lipid metabolism in human muscle in vivo:
the effect of hyperinsulinemia. Department of Medicine, Helsinki University Hospital,
Finland. Metabolism. 1997 Dec;46(12):1454-7.
25. Vermeulen RC, Scholte HR. Exploratory open label, randomized study of acetyl-
and propionylcarnitine in chronic fatigue syndrome. Research Center Amsterdam,
Amsterdam, Netherlands. Psychosom Med. 2004 Mar-Apr;66(2):276-82.
26. Adriani W, Rea M, Baviera M, Invernizzi W, Carli M, Ghirardi O, Caprioli
A, Laviola G. Acetyl-L-carnitine reduces impulsive behaviour in adolescent rats.
Behavioural Neuroscience Section, Dept. Cell Biology & Neurosciences,
Istituto Superiore di Sanita', viale Regina Elena 299, 00161 Rome, Italy. Psychopharmacology
(Berl). 2004 Nov;176(3-4):296-304. Epub 2004 May 8.
27. Chiechio S, Copani A, Melchiorri D, Canudas AM, Storto M, Calvani M, Nicolai
R, Nicoletti F. Metabotropic receptors as targets for drugs of potential use
in the treatment of neuropathic pain. Department of Pharmaceutical Science, University
of Catania, Catania, Italy. J Endocrinol Invest. 2004;27 Suppl(6):171-6.
28. Virmani A, Binienda Z. Role of carnitine esters in brain neuropathology.
Scientific Affairs, Sigma-tau HealthScience, Pomezia 00040, Italy. ashraf.virmani@st-hs.it
Mol Aspects Med. 2004 Oct-Dec;25(5-6):533-49.
- Sorbi S, Forleo P, Fani C, Piacentini S. Double-blind, crossover, placebo-controlled
clinical trial with L-acetylcarnitine in patients with degenerative cerebellar
ataxia. Department of Neurological and Psychiatric Sciences, University of Florence,
Italy. Clin Neuropharmacol. 2000 Mar-Apr;23(2):114-8.
29. De Grandis D, Minardi C. Acetyl-L-carnitine (levacecarnine) in the treatment
of diabetic neuropathy. A long-term, randomised, double-blind, placebo-controlled
study. Department of Neuroscience, Ospedale Civile, Rovigo, Italy. ddegrandis@iol.it
Drugs R D. 2002;3(4):223-31.
30. Cavallini G, Modenini F, Vitali G, Koverech A. Acetyl-L-carnitine plus propionyl-L-carnitine
improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral
nerve-sparing radical retropubic prostatectomy. Operative Unit of Andrology,
Societa Italiana di Medicina della Riproduzione, Bologna, Italy. giorgiocavallini@libero.it
Urology. 2005 Nov;66(5):1080-5.
Literatura:
Dr. Ronald Klatz, MD. Robert Goldman - Stopping the Clock: Dramatic Breakthroughs in Anti-Aging and Aging Reversal Techniques
Dr. MD. Roy L Waldford - Beyond the 120 Year Diet: How to Double Your Vital Years
Parerea din pasajele acestui site nu a fost independent cercetate sau confirmate.
|
Anti-Aging-Systeme
© 2008
|
Design by NB |